The production site for a syringe for corona 19 vaccination in Shin-A Yanghaeng Co., Ltd., Gongju-si, Chungnam, was unveiled on the 2nd. It is a minimal residual type (LSD) syringe suitable for vaccination, the government explained. yunhap news
Japan, which plans to start vaccinating Corona 19 after mid-next week, encountered an unexpected’syringe’ challenge. On the 10th, Gwa et al. reported that the Japanese Ministry of Health, Labor and Welfare announced at the National Assembly the day before that the number of vaccinations per bottle of Pfizer vaccine was changed from 6 to 5, and that it was notified to local governments across the country. According to the Ministry of Health and Welfare, Pfizer’s vaccine is a method in which 0.3 ml of undiluted solution is taken out of the bottle with a syringe, diluted in physiological saline, and injected into the muscles. To inoculate 6 times a bottle, a special syringe with a small amount of vaccine remaining at the end of the syringe is required, but the syringes that have been secured so far will leave the vaccine at the tip of the needle or in the syringe. The Japanese government, which had already prepared 200 million syringes for vaccination since the summer of last year, finally learned this fact last month. It took a lot of time to secure enough syringes for 6 reps, so we decided to reduce the number of times per bottle. Japan, which signed a contract with Pfizer to receive a supply of 144 million doses (72 million people) of vaccine on the premise of six doses per bottle, will reduce the total number of vaccinations by 24 million (12 million people) with this decision. While the Ministry of Health and Welfare is promoting the expansion of the purchase of special syringes, it is also saying that it will secure the original target amount of 144 million doses through consultation with Pfizer, but there are many prospects that there will be a setback in the size of inoculations. The Ministry of Health and Welfare will approve Pfizer’s COVID-19 vaccine on the 15th and start vaccination for 10,000 medical workers who have agreed to the purpose of the safety investigation from the 17th. Meanwhile, Korea announced the production site of Shin-A Yanghaeng, a manufacturer that makes’least residual type’ (LDS) syringes last week, and the government promised export support. By Kim Young-hee, staff reporter [email protected]